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Abstract
Background: Direct immunofluorescence assays (DFA) are a rapid and inexpensive method for the detection of
respiratory viruses and may therefore be used for surveillance. Few epidemiological studies have been published
based solely on DFA and none included respiratory picornaviruses and human metapneumovirus (hMPV). We
wished to evaluate the use of DFA for epidemiological studies with a long-term observation of respiratory viruses
that includes both respiratory picornaviruses and hMPV.
Methods: Since 1998 all children hospitalized with respiratory illness at the University Hospital Bern have been
screened with DFA for common respiratory viruses including adenovirus, respiratory syncytial virus (RSV), influenza
A and B, and parainfluenza virus 1-3. In 2006 assays for respiratory picornaviruses and hMPV were added. Here we
describe the epidemiological pattern for these respiratory viruses detected by DFA in 10’629 nasopharyngeal
aspirates collected from 8’285 patients during a 12-year period (1998-2010).
Results: Addition of assays for respiratory picornaviruses and hMPV raised the proportion of positive DFA results
from 35% to 58% (p < 0.0001). Respiratory picornaviruses were the most common viruses detected among patients
≥1 year old. The seasonal patterns and age distribution for the studied viruses agreed well with those reported in
the literature. In 2010, an hMPV epidemic of unexpected size was observed.
Conclusions: DFA is a valid, rapid, flexible and inexpensive method. The addition of assays for respiratory
picornaviruses and hMPV broadens its range of viral detection. DFA is, even in the “PCR era”, a particularly adapted
method for the long term surveillance of respiratory viruses in a pediatric population.
Background
Respiratory infections are a major cause of morbidity
and hospitalizations in children [1], of which a signifi-
cant proportion are caused by viruses [2,3]. Surveillance
of respiratory viruses is important to predict seasonal
epidemics, to define patient risk groups and to allocate
hospital resources, as well as to describe the burden and
characteristics of emerging viruses [4].
In the field of virology, the most commonly used diag-
nostic methods for virus detection are culture, rapid
culture (such as shell vial assay), direct immunofluores-
cence staining of clinical specimens (DFA), and PCR.
PCR is attractive due to its high sensitivity and broad
range of virus detection. PCR-based studies have sug-
gested the important role of respiratory picornaviruses
(rhinovirus and enterovirus) as a leading cause of lower
respiratory tract infections in children [5], in particular
wheezing illnesses such as bronchiolitis [6,7], wheezy
bronchitis [8] and asthma exacerbations [9], but also
pneumonia [2]. In addition, PCR has allowed for the
detection of new respiratory viruses, such as hMPV [10],
which has been implicated in upper and lower respira-
tory tract infections in children [11-13]. It is widely * Correspondence: meri.gorgievski@ifik.unibe.ch
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respiratory viruses can only be done with PCR.
However, the high sensitivity of PCR is also a limita-
tion of the technique. A significant proportion of
asymptomatic children test positive by PCR to respira-
tory viruses [14-16], and picornavirus RNA can be
detected by PCR up to 5 weeks after an acute infection
[17]. Therefore, epidemiological studies based on PCR
may overestimate the burden of certain viruses, in parti-
cular the common respiratory picornaviruses.
DFA has lower sensitivity than PCR, but this may be
an advantage for the detection of clinically relevant
infections [18,19]. Moreover, DFA is more rapid and
less expensive than PCR and can therefore be used for
real-time, routine surveillance of respiratory viruses,
which would be difficult by PCR because of the high
costs [20,21]. Nevertheless only few epidemiological stu-
dies have been published based solely on DFA [22,23],
and none of them included testing for respiratory picor-
naviruses or hMPV, because antibodies for the detection
of hMPV have only recently become available and there
are no commercial antibodies for the detection of
respiratory picornaviruses. Recently, our group reported
the validity of immunofluorescence for the detection of
picornaviruses directly in respiratory samples using
monoclonal antibodies originally designed for the identi-
fication of enterovirus in culture [24].
We aimed to evaluate the use of DFA for epidemiolo-
gical studies of respiratory viruses, now that assays for
respiratory picornaviruses and hMPV are available. We
performed a retrospective analysis among pediatric
patients hospitalized with respiratory tract infections
between 1998 and 2010 at the University Hospital Bern.
Prospective DFA testing in nasopharyngeal aspirates has
been used routinely in this institution for adenovirus
(ADV), respiratory syncytial virus (RSV), influenza A
and B (IFA and IFB), and parainfluenza 1-3 (PIV 1-3)
since 1998, and additionally for hMPV and respiratory
picornaviruses since 2006.
Methods
Patient population and sample collection
The study was approved by the Ethics Committee of the
University Hospital of Bern in accordance with cantonal
ethical regulations (Nr. E 10-01-10). The study included
consecutive respiratory tract samples from children
under the age of 17 years, who were hospitalized at the
Department of Pediatrics, University Hospital Bern,
between May 1
st 1998 and April 30
th 2010. During the
entire study period the pediatrics department had the
policy of screening children for respiratory viruses if
they were hospitalized with a respiratory illness or if
they developed respiratory symptoms during their hospi-
tal stay.
A total of 12’189 respiratory samples were collected.
After exclusion criteria, 10’629 samples remained for the
retrospective analysis of DFA results. The exclusion cri-
teria were as follows: samples other than nasopharyngeal
aspirates, samples containing less than 20 epithelial cells
and samples not tested against the whole viral panel;
results of samples from the same patient taken within a
time period of 7 days (considered part of the same
respiratory episode); results for the month of August
2009, since during this time period practically all
respiratory samples were tested by PCR rather than
DFA due to the influenza A H1N1 pandemic.
Direct immunofluorescence testing (DFA) for respiratory
viruses
All samples were analysed at the Institute for Infectious
Diseases, University of Bern. The methods used have
previously been described [24].
Between May 1
st 1998 and August 31
st 2007, the Light
Diagnostics Respiratory Viral Screen DFA (Chemicon
International, now Millipore) and single fluorescein-con-
jugated monoclonal antibodies against ADV, RSV, IFA,
IFB and PIV 1-3 were used. From September 1
st 2007 to
April 30
th 2010, the D3 Ultra DFA Respiratory Virus
Screening & ID Kit (Diagnostic Hybrids) was used for
the same viruses. Starting in March 2006, the Light
Diagnostics Pan-Enterovirus Reagent “Blend” (Chemicon
International/Millipore) was introduced for the detec-
tion of respiratory picornaviruses. This assay is formally
an indirect immunofluorescence assay, as described else-
where [24], and does not allow the differentiation
between rhinoviruses and enteroviruses. In November
2006, the DFA Metapneumovirus Identification Kit
(Diagnostic Hybrids) was added to the screening.
Statistical analysis
An epidemiological year was defined as May 1
st to April
30
th of the following year. Summer was defined as the
months July to September, and winter as January to
March. Epidemiological years were designated “odd” if the
month of January was in an odd year, and they were
labelled “even” if the month of January was in an even year.
All statistical analyses were performed with the
GraphPad Prism 5
® software tool (GraphPad Software,
Inc.). Proportions were compared using the chi-square
test. Medians were compared with the Kruskal-Wallis
test and Dunn’s multiple comparison test. A cut-off of p
≤ 0.05, two tailed, was used for all statistical analyses.
Results
Population
A total of 10’629 samples from 8’285 patients were ana-
lysed. The median age of the study population was 11
months (range 0-17 years) and 57.5% were boys.
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Page 2 of 7Rate of viral detection
Before the addition of DFA for picornavirus and hMPV,
the rate of viral detection was dominated by the RSV
season, with a yearly average rate of 35%, peaks of up to
64% (average 46%) in winter seasons, and troughs as
low as 4% (average 16%) during summer time. The addi-
tion of DFA for picornaviruses increased the positivity
rate, and dampened the seasonal variations. The positiv-
ity rate after 2006 was on average 65% in winter and
52% in summer, with a yearly average of 58% (versus
35%; p < 0.0001) (Figure 1, Table 1). For comparison,
analysis performed on 256 specimens in parallel to DFA
screening with the xTag Respiratory Viral Panel (Lumi-
nex Molecular Diagnostics) between November 2006
and September 2007 yielded a positivity rate of 78%.
The higher detection rate by PCR could mostly be
attributed to increased detection of respiratory picorna-
viruses; 57 from the 78 additional positive results were
respiratory picornaviruses (unpublished data).
Pathogens
Respiratory picornaviruses were the most common
pathogens detected overall in our study population after
the introduction of the assay (27% versus 21% for RSV; p
< 0.0001) (Table 1). They were present year round, with
peaks in the spring and the fall. During the summer time,
respiratory picornaviruses also accounted for the majority
of viral respiratory infections (Figure 1). Low prevalence
of respiratory picornaviruses during winter time coin-
cided with the winter peaks caused by RSV, influenza, or
hMPV, and this was the only time during the year when
respiratory picornaviruses were not the most commonly
detected respiratory virus (Figure 2).
RSV was the second most commonly detected patho-
gen after picornaviruses (overall prevalence of 21%), but
the most prevalent virus during the winter months
(Table 1, Figure 2). It manifested a biennial pattern,
with large winter seasons in odd years alternating with
smaller ones in even years.
Influenza A virus was found in 4.1% of all samples and
caused yearly winter epidemics, except during the winter
season 2005-2006 when it was replaced by influenza B
virus (Table 1, Figure 2).
hMPV was detected in 3.4% of all samples collected
after November 2006 (Table 1). Yearly hMPV activity
varied from being almost absent during the winter sea-
son 2006 to 2007, to causing yearly winter outbreaks
during the following years (Figure 2, Figure 3). In early
2010, viral activity surpassed previous years, with more
cases observed within 5 months (71 cases between
December 2009 and April 2010) than during the entire
previous period since introduction of the DFA test (56
cases between November 2006 and November 2009).
Age distribution
We compared the proportion of samples positive for a
given virus by age (Figure 4). Respiratory picornaviruses
were the most common pathogens in children ≥1y e a r s
(1-4 years: 33% versus 15% RSV, p < 0.0001; 5-8 years:
26% versus <7% other viruses, p < 0.0001; 9-17 years:
16% versus 9% influenza A, p = 0.007), and RSV was the
most common detected in children <1y e a r(30% ver-
sus 23% picornavirus, p < 0.0001). Influenza A showed
growing importance with age, and was the second most
common virus detected in children >9 years old (9%
influenza A versus <4% other viruses, p < 0.0001).
Codetection of respiratory viruses
O u to ft h et o t a lo f1 0 ’629 samples analysed, 82 were
positive for two viruses (Table 2). No sample was posi-
tive for more than two viruses. This corresponds to a
codetection rate of 0.8% with DFA.
With the xTag Respiratory Viral Panel (Luminex)
10.2% of samples were positive for two viruses (in 81%
of these a respiratory picornavirus was present). In 0.8%
of samples we detected three respiratory viruses.
Discussion
In order to determine the value of DFA in conducting
epidemiological studies on respiratory viruses now that
assays for respiratory picornaviruses and hMPV are
available, we retrospectively analysed the results of 12
years of DFA screening of viral pathogens in hospita-
lized children with respiratory disease.
Respiratory picornaviruses were the most common
viral pathogens detected overall in our study, with the
exception of patients <1 year in whom RSV was
detected more often, confirming the results of recent
studies based on molecular methods [25,26]. PCR detec-
tion of respiratory picornaviruses suggests a previously
unexpected role [27,28] in severe respiratory disease
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Figure 1 Mean monthly distribution of respiratory viruses
detected by DFA in nasopharyngeal aspirates from
hospitalized children from November 2006 to April 2010.
picorna = respiratory picornaviruses; hMPV = human
metapneumovirus; others = adenovirus, respiratory syncytial virus,
influenza A and B, parainfluenza viruses 1-3.
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Page 3 of 7Table 1 Proportion (%) of positive DFA results in nasopharyngeal aspirates by virus and by year, 1998-2010
Epidemiogical
years
98/99 99/00 00/01 01/02 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 1998-
2010
1998-
2006
2006-
2010
ADV 3333124432233
RSV 32 15 32 12 31 15 26 13 26 15 23 12 21
IFA 71 2 264660 . 2 32324
IFB 2 0 0 2 1 0 0.1 2 0 0.2 0.4 0 0.6
PIV 5453463223444
hMPV 0.2 4 1 8 3
Picorna 2 2 42 63 32 827
Total 49 34 43 26 41 29 38 24 57 53 66 57 44 35 58
Summer 28 16 15 10 24 20 8 4 48 48 63 43 16 52
Winter 58 42 58 34 41 40 64 33 60 60 70 68 46 65
An epidemiological year lasts from May 1st to April 30th of the following year.
ADV = adenovirus; RSV = respiratory syncytial virus; IFA = influenza A; IFB = influenza B; PIV = parainfluenza viruses 1-3;
hMPV = human metapneumovirus; picorna = respiratory picornaviruses.
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Figure 2 Monthly distribution of respiratory viruses detected by DFA in nasopharyngeal aspirates from hospitalized children between
May 1998 and April 2010, with introduction of the hMPV and respiratory picornavirus assays in 2006. A: All viruses detected. B: Detailed
view of ADV, IFB and PIV (note that the scale is different than in A). ADV = adenovirus; RSV = respiratory syncytial virus; IFA = influenza A; IFB =
influenza B; PIV = parainfluenza viruses 1-3; hMPV = human metapneumovirus; picorna = respiratory picornaviruses.
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Page 4 of 7[25,26,29], but this issue is still debated, given that viral
genome can also be detected by PCR many weeks after
an acute viral infection [17], or even in entirely asymp-
tomatic children [16,30]. DFA assays need a high viral
load to score positive, so a positive result may be more
indicative of an acute infection caused by the virus
[18,19]. Our high detection rate of respiratory picorna-
viruses by DFA in hospitalized patients therefore sup-
ports their high burden of disease.
The introduction of the hMPV and respiratory picor-
navirus assays in 2006 increased the positivity rate of
our DFA screening from 35% to 58%. For comparison,
PCR methods in our laboratory and in the literature
usually reach positivity rates of well over 70%, in large
part due to a higher detection of respiratory picorna-
viruses [6,7,26,31]. DFA’s lower sensitivity, in particular
for respiratory picornaviruses, can however be seen as
an advantage considering the difficulty in interpreting
the clinical significance of PCR-positive results, as
described above.
Another common issue in PCR-based studies is the
high codetection rate, with on average about 20% of
samples being positive for two or more viruses [3,26].
With the xTag Respiratory Viral Panel we detected
more than one virus in 11% of samples. In 81% of these
a respiratory picornavirus was present. The clinical sig-
nificance of these “coinfections” remains unclear
because of the high sensitivity of PCR [3,32,33], espe-
cially for respiratory picornaviruses. It is difficult to
determine whether both or only one and which of the
codetected pathogens is causing the acute illness [30].
Our lower rate of codetection by DFA suggests that
most codetections detected by PCR may indicate conse-
cutive infections.
With the exception of hMPV, our study confirms
known patterns of seasonality and age distribution for
the studied viruses [22,26,34,35]. It has been postulated
that hMPV has a biennial “large-early” and “small-late”
season cycle [26,36-38]. We observed an unexpectedly
large epidemic in early 2010, which was observed simul-
taneously in many cities throughout Germany (personal
communication, Prof. O. Adams, University of Düssel-
dorf). Given the recent discovery of hMPV [10], epide-
miological studies so far have covered a short time
interval and continued monitoring is necessary.
Currently, PCR is considered the most adapted techni-
que to conduct epidemiological studies on respiratory
viruses. In contrast to molecular methods, DFA is low
in cost and has a rapid turnaround time [21]. Assays
can be performed many times a day, and one does not
have to wait for a certain number of samples to be col-
lected to start a run. The samples can be screened for
many different viruses simultaneously ("multiplex”).
Results are usually available within 2-3 hours [39].
These aspects make DFA a method widely and often
used in clinical routine, and this concurrently provides
the data for ongoing, real-time surveillance of circulating
viral pathogens on a large scale. Our systematic moni-
toring led for example to the early detection of the
unexpectedly large hMPV epidemic mentioned above.
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Figure 3 Monthly human metapneumovirus detection by DFA
in nasopharyngeal aspirates from hospitalized children
between November 2006 and April 2010.
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Figure 4 Proportion of nasopharyngeal aspirates from
hospitalized children positive by DFA for respiratory viruses
according to age and virus. Based on 1998-2010 data for
adenovirus (ADV), respiratory syncytial virus (RSV), influenza A (IFA),
influenza B (IFB) and parainfluenza viruses 1-3 (PIV). Based on 2006-
2010 data for human metapneumovirus (hMPV) and respiratory
picornaviruses (picorna). Note: due to a low number of samples,
data for the 16-17 year olds is not shown.
Table 2 Number of nasopharyngeal aspirates with viral
codetections by DFA
picorna hMPV PIV IFB IFA RSV
ADV 92 4 0 2 1 0
RSV 29 0 0 1 7
IFA 10 4
PIV 91
hMPV 3
ADV = adenovirus; RSV = respiratory syncytial virus; IFA = influenza A; IFB =
influenza B; PIV = parainfluenza viruses 1-3; hMPV = human
metapneumovirus; picorna = respiratory picornaviruses.
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Page 5 of 7Conclusions
In conclusion, DFA’s clinical relevance, flexibility and
capacity to conduct “multiplex” assays at very low cost
make it a valuable diagnostic tool, and now that its
range of viral detection has been broadened to include
hMPV and especially respiratory picornaviruses, allows
for long-term, systematic, real-time monitoring of local
epidemiology in pediatric populations.
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